Neurofilament light chain (NfL) is a biomarker of neuronal injury in hereditary ATTR (ATTRv) amyloidosis. However, the correlation between NfL and nerve conduction study (NCS), the standard test for A
Two studies examined for a relationship between two different biomarker modalities (MRI and MRS in one study; MRI and CSF in another study) and a clinical measure of disease progression. (MRI, magneti
The Brain Biomarker market is an integral segment of the biopharmaceutical and diagnostic industry, focusing on the biological indicators associated with neurological conditions, such as Alzheimer's d